🇺🇸 FDA
Patent

US 8461163

Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1

granted A61KA61K31/519A61P

Quick answer

US patent 8461163 (Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1) held by Takeda Pharmaceutical Company Limited expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
36
CPC classes
A61K, A61K31/519, A61P, A61P1/00, A61P1/04